| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $63.5M | -34.0% |
| R&D Expense | $172.6M | -46.1% |
| SG&A Expense | $81.4M | -3.3% |
| Operating Income | -$190.5M | +38.2% |
| Income Tax | $0 | — |
| Net Income | -$160.9M | +42.9% |
| EPS (Basic) | -$1.64 | +43.6% |
| EPS (Diluted) | -$1.64 | +43.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.9M | -31.7% |
| Short-term Investments | $273.3M | -27.1% |
| Accounts Receivable | $1.8M | -95.3% |
| Current Assets | $331.5M | -34.0% |
| Total Assets | $506.2M | -28.3% |
| Current Liabilities | $39.1M | -65.7% |
| Stockholders' Equity | $368.4M | -23.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$132.3M | +46.7% |
| Capital Expenditures | $6.2M | -82.7% |
| Investing Cash Flow | $112.7M | -32.4% |
| Financing Cash Flow | $85K | -99.1% |
| Free Cash Flow | -$138.4M | +51.2% |